Reviva Pharmaceuticals Holdings, Inc. Cash and Restricted Cash
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Cash and Restricted Cash of $36.59 thousand as of 2020-11-30, per its 10-Q filed 2021-01-14.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2021-01-14
- 2020-11-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $36.59K.
- 2020-08-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.54K.
- 2020-05-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $197.98K.
- 2020-02-29: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $69.28K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2020-11-30 | $36.59K 10-Q · filed 2021-01-14 |
| 2020-08-31 | $15.54K 10-Q · filed 2020-10-14 |
| 2020-05-31 | $197.98K 10-Q · filed 2020-07-07 |
| 2020-02-29 | $69.28K 10-Q · filed 2021-01-14 |
| 2019-11-30 | $134.31K 10-Q · filed 2021-01-14 |
| 2019-08-31 | $211.24K 10-Q · filed 2020-10-14 |
| 2019-05-31 | $273.69K 10-Q · filed 2020-07-07 |
| 2019-02-28 | $313.05K 10-Q · filed 2021-01-14 |
| 2018-11-30 | $400.96K 10-Q · filed 2020-01-10 |
| 2018-08-31 | $441.57K 10-Q · filed 2019-10-08 |
| 2018-03-19 | $0.00 10-Q · filed 2020-01-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |